Oxycodoni hydrochloridum, Naloxoni hydrochloridum
| Medicinal product name | Geroxynal 30 mg/15 mg prolonged-release tablets |
|---|---|
| Pharmaceutical form | Prolonged-release tablet |
| Strength | 30 mg/15 mg |
| Information from the MAH on shortages | Not notified |
| Legal status | Prescription (Pr.I) |
| Package leaflet |  06-06-2023
|
| Summary of product characteristics | 06-06-2023
|
| ATC code | N02AA55 – Analgesics |
| Information for Marketing authorisation holders | View |
Medicinal products (11)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N7 (30 mg/15 mg) |
PVC/PVDC/Al blister | 17-0236-01 |
 Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N10 (30 mg/15 mg) |
PVC/PVDC/Al blister | 17-0236-02 |
Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N14 (30 mg/15 mg) |
PVC/PVDC/Al blister | 17-0236-03 |
Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20 (30 mg/15 mg) |
PVC/PVDC/Al blister | 17-0236-04 |
Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N28 (30 mg/15 mg) |
PVC/PVDC/Al blister | 17-0236-05 |
Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30 (30 mg/15 mg) |
PVC/PVDC/Al blister | 17-0236-06 |
Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N50 (30 mg/15 mg) |
PVC/PVDC/Al blister | 17-0236-07 |
Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N56 (30 mg/15 mg) |
PVC/PVDC/Al blister | 17-0236-08 |
Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60 (30 mg/15 mg) |
PVC/PVDC/Al blister | 17-0236-09 |
Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N98 (30 mg/15 mg) |
PVC/PVDC/Al blister | 17-0236-10 |
Labelling text Sep 27, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (30 mg/15 mg) |
PVC/PVDC/Al blister | 17-0236-11 |
Labelling text Sep 27, 2018 |
Registration information
| Marketing authorisation No. | 17-0236 |
|---|---|
| Date of authorisation | Oct 25, 2017 |
| Marketing authorisation holder, country | G.L. Pharma GmbH, Austria |
